9 September, 2021 - Press notes
Researchers from the Hospital del Mar Medical Research Institute (IMIM) have discovered a novel mechanism through which the serotonin receptor interacts with cell membranes in the human brain. This finding opens the door for the design of novel drugs, which could treat central nervous system disorders.
6 August, 2021 - Press notes
The team led by Dr. Edurne Arriola and Dr. Beatriz Bellosillo will receive a grant from Thermo Fisher Scientific for their research on the application of liquid biopsy in patients with metastatic small cell lung cancer. The aim is to determine new treatment and prognostic biomarkers in patients with this type of tumour. They will also look for possible new therapeutic targets. This innovative project is one of four selected from around the world to be promoted within the Oncomine Clinical Research Grant programme, and it will look at data from 300 patients with this pathology.
10 August, 2021 - Press notes
The Director of the Healthcare and Medical Area, head of the General and Digestive Surgery Service and co-coordinator of the Clinical and Translational Research Group on Colorectal Neoplasms at the Hospital del Mar Medical Research Institute, is one of the top specialists among Catalan digestive surgeons.
29th July, 2021 - Press notes
Researchers at the Hospital del Mar Medical Research Institute have shown for the first time how small areas of proteins on the surface of neurones control cell response by binding to neurotransmitters. Evolution has led to the existence of proteins with variations in these areas, capable of causing different cellular responses. This makes it possible to precisely regulate the neurone's response to the same neurotransmitter. It paves the way for the development of specific molecules that block areas linked to certain mental illnesses, such as schizophrenia, or to addictive behaviour. It is the first time it has been possible to see how neurotransmitters and proteins interact at the atomic level to trigger neuronal responses. The study has been published in the journal Chemical Science.
21th July, 2021 - Press notes
A 1% increase in this substance in the blood is associated with a change in mortality risk similar to that of quitting smoking. Conversely, being a smoker cancels out the positive effect of eating oily fish, the main source of omega-3 acids. The study, published in The American Journal of Clinical Nutrition, analysed data from more than 2,000 people participating in a population-based follow-up programme in the United States. Their progress has been studied over an eleven-year period. The researchers will try to validate the data using a European population.
15th July 2021 - Press notes
Two professionals from the Laboratory will travel to the Japanese capital to support the anti-doping work that will take place during the Olympic Games, which begin on July 23.
13th July 2021 - Press notes
Combining chemotherapy with a BRAF oncogene inhibitor proves effective at treating this disease. The study, published in the journal Oncogene, was led by researchers from the Hospital del Mar Medical Research Institute, Hospital del Mar and CIBERONC. This alternative paves the way towards a new approach for patients affected by this type of tumour, which has no cure in the most advanced stages or cases of relapse.
July 8th 2021 - Press notes
The IMIM has obtained nearly 3.4 million euros in financing from this fund, 12% more than in the 2019 call for proposals, the most recent prior to the pandemic. 60% of the proposals submitted were approved, a record number in the history of the institution.
22nd June, 2021 - Press notes
A study in 27 European countries led by researchers from King's College London and the Hospital del Mar Medical Research Institute puts the prevalence of depression at 6.4% of the population. The work, published in The Lancet Public Health, analysed data from the European Health Interview Survey, which includes responses from more than 250,000 people. The incidence is higher in women at 7.7 per cent, while in men it is 4.9 per cent. Strong differences are seen between countries, with higher rates in more economically developed states.
June 15 th, 2021 - Press release
On June 15th and 16th, the STOPSTORM consortium coordinated by the UMC Utrecht with the IMIM and Hospital del Mar's participation, met virtually to discuss early project progress. The project, which officially started on May 1st, will begin researching the use of radiotherapy in treating cardiac arrhythmias. Patients who suffer from ventricular tachycardia (fibrillation of the ventricles) are often treated with medication and/or implantation of an ICD, a defibrillator that corrects a rapid heart rate with an electric shock. In cases of persistent arrhythmias that do not respond adequately to regular therapy, patients may undergo invasive catheter ablation.
Parc Salut Mar
Passeig Marítim 25-29 Barcelona 08003
See location on Google maps
Phone: 93 248 30 00 · Fax: 93 248 32 54
Information request
© 2006 - 2024 Hospital del Mar · Legal notice and Privacy Police | Cookie Policy | Accessibility
